<DOC>
	<DOC>NCT00645515</DOC>
	<brief_summary>The purpose of this study is to compare the safety of ziprasidone and risperidone for the treatment of chronic schizophrenia. The primary purpose is to differentiate the effects of ziprasidone and risperidone on extrapyramidal side effects and the secondary purpose is to compare their tolerability and efficacy.</brief_summary>
	<brief_title>A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis of schizophrenia CGIS score of 4 or less at baseline Concurrent antipsychotic treatment Treatment with antidepressants or mood stabilizers within 2 weeks of randomization Acute exacerbation of schizophrenia within 3 months of baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>